Lung and gut microbiome in CC-LR mouse model affected by clarithromycin treatment
The goal is to assess the effect of clarithromycin on lung and gut microbiome in mice with K-ras mutant lung cancer. CC-LR mice were treated with clarithromycin oral gavage 5 days per week for a total of ten weeks.